L-Proline induces differentiation of ES cells: a novel role for an amino acid in the regulation of pluripotent cells in culture
Washington, Jennifer M, Rathjen, Joy, Felquer, Fernando, Lonic, Ana, Bettess, Michael D, Hamra, Nancy, Semendric, Ljiljana, Tan, Boon Siang Nicholas, Lake, Julie-Anne, Keough, Rebecca A, Morris, Michael B, Rathjen, Peter D
Published in American Journal of Physiology: Cell Physiology (01.05.2010)
Published in American Journal of Physiology: Cell Physiology (01.05.2010)
Get full text
Journal Article
Src Family Kinases and p38 Mitogen-Activated Protein Kinases Regulate Pluripotent Cell Differentiation in Culture
Tan, Boon Siang Nicholas, Kwek, Joly, Wong, Chong Kum Edwin, Saner, Nicholas J, Yap, Charlotte, Felquer, Fernando, Morris, Michael B, Gardner, David K, Rathjen, Peter D, Rathjen, Joy
Published in PloS one (10.10.2016)
Published in PloS one (10.10.2016)
Get full text
Journal Article
Congenital hydrocephalus and abnormal subcommissural organ development in Sox3 transgenic mice
Lee, Kristie, Tan, Jacqueline, Morris, Michael B, Rizzoti, Karine, Hughes, James, Cheah, Pike See, Felquer, Fernando, Liu, Xuan, Piltz, Sandra, Lovell-Badge, Robin, Thomas, Paul Q
Published in PloS one (26.01.2012)
Published in PloS one (26.01.2012)
Get full text
Journal Article
14-3-3:Shc Scaffolds Integrate Phosphoserine and Phosphotyrosine Signaling to Regulate Phosphatidylinositol 3-Kinase Activation and Cell Survival
Barry, Emma F., Felquer, Fernando A., Powell, Jason A., Biggs, Lisa, Stomski, Frank C., Urbani, Andrea, Ramshaw, Hayley, Hoffmann, Peter, Wilce, Matthew C., Grimbaldeston, Michele A., Lopez, Angel F., Guthridge, Mark A.
Published in The Journal of biological chemistry (01.05.2009)
Published in The Journal of biological chemistry (01.05.2009)
Get full text
Journal Article
Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch
Guthridge, Mark A, Powell, Jason A, Barry, Emma F, Stomski, Frank C, McClure, Barbara J, Ramshaw, Hayley, Felquer, Fernando A, Dottore, Mara, Thomas, Daniel T, To, Bik, Begley, C Glenn, Lopez, Angel F
Published in The EMBO journal (08.02.2006)
Published in The EMBO journal (08.02.2006)
Get full text
Journal Article
The phosphoserine-585–dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-κB and induction of bcl-2
Guthridge, Mark A., Barry, Emma F., Felquer, Fernando A., McClure, Barbara J., Stomski, Frank C., Ramshaw, Hayley, Lopez, Angel F.
Published in Blood (01.02.2004)
Published in Blood (01.02.2004)
Get full text
Journal Article
L-Proline induces differentiation of ES cells: a novel role for an amino acid in the regulation of pluripotent cells in culture
WASHINGTON, Jennifer M, RATHJEN, Joy, MORRIS, Michael B, RATHJEN, Peter D, FELQUER, Fernando, LONIC, Ana, BETTESS, Michael D, HAMRA, Nancy, SEMENDRIC, Ljiljana, NICHOLAS TAN, Boon Siang, LAKE, Julie-Anne, KEOUGH, Rebecca A
Published in American Journal of Physiology: Cell Physiology (2010)
Get full text
Published in American Journal of Physiology: Cell Physiology (2010)
Journal Article
14-3-3:Shc Scaffolds Integrate Phosphoserine and Phosphotyrosine Signaling to Regulate Phosphatidylinositol 3-Kinase Activation and Cell SurvivalS
Barry, Emma F., Felquer, Fernando A., Powell, Jason A., Biggs, Lisa, Stomski, Frank C., Urbani, Andrea, Ramshaw, Hayley, Hoffmann, Peter, Wilce, Matthew C., Grimbaldeston, Michele A., Lopez, Angel F., Guthridge, Mark A.
Published in The Journal of biological chemistry (01.05.2009)
Published in The Journal of biological chemistry (01.05.2009)
Get full text
Journal Article
A PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING TRYPSINOGEN AND/OR CHYMOTRYPSINOGEN AND AN ACTIVE AGENT SELECTED FROM A SELENIUM COMPOUND, A VANILLOID COMPOUND AND A CYTOPLASMIC GLYCOLYSIS REDUCTION AGENT
TOSH, DAVID, BRANDT, RALF, CLAYTON, PAUL RODNEY, FELQUER, FERNANDO, KENYON, JULIAN NORMAN
Year of Publication 26.09.2023
Get full text
Year of Publication 26.09.2023
Patent
The phosphoserine-585-dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-kappaB and induction of bcl-2
Guthridge, Mark A, Barry, Emma F, Felquer, Fernando A, McClure, Barbara J, Stomski, Frank C, Ramshaw, Hayley, Lopez, Angel F
Published in Blood (01.02.2004)
Get full text
Published in Blood (01.02.2004)
Journal Article
Pharmaceutical Composition for Treating Cancer Comprising Trypsinogen and/or Chymotrypsinogen and an Active Agent Selected from a Selenium Compound, a Vanilloid Compound and a Cytoplasmic Glycolysis Reduction Agent
Tosh, David, Brandt, Ralf, Clayton, Paul Rodney, Felquer, Fernando, Kenyon, Julian Norman
Year of Publication 04.05.2023
Get full text
Year of Publication 04.05.2023
Patent
Pharmaceutical Composition for Treating Cancer Comprising Trypsinogen and/or Chymotrypsinogen and an Active Agent Selected from a Selenium Compound, a Vanilloid Compound and a Cytoplasmic Glycolysis Reduction Agent
Tosh, David, Brandt, Ralf, Clayton, Paul Rodney, Felquer, Fernando, Kenyon, Julian Norman
Year of Publication 26.12.2019
Get full text
Year of Publication 26.12.2019
Patent
Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
Tosh, David, Brandt, Ralf, Clayton, Paul Rodney, Felquer, Fernando, Kenyon, Julian Norman
Year of Publication 16.07.2019
Get full text
Year of Publication 16.07.2019
Patent
FARMACEUTISK SAMMENSÆTNING TIL BEHANDLING AF CANCER OMFATTENDE TRYPSINOGEN OG CHYMOTRYPSINOGEN
Tosh, David, Brandt, Ralf, Clayton, Paul Rodney, Felquer, Fernando, Kenyon, Julian Norman
Year of Publication 19.11.2018
Get full text
Year of Publication 19.11.2018
Patent
PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING TRYPSINOGEN AND CHYMOTRYPSINOGEN
DAVID TOSH, PAUL RODNEY CLAYTON, FERNANDO FELQUER, JULIAN NORMAN KENYON, RALF BRANDT
Year of Publication 09.11.2018
Get full text
Year of Publication 09.11.2018
Patent
PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING TRYPSINOGEN AND CHYMOTRYPSINOGEN
Tosh, David, Brandt, Ralf, Clayton, Paul Rodney, Felquer, Fernando, Kenyon, Julian Norman
Year of Publication 25.07.2018
Get full text
Year of Publication 25.07.2018
Patent
A PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING TRYPSINOGEN AND/OR CHYMOTRYPSINOGEN AND AN ACTIVE AGENT SELECTED FROM A SELENIUM COMPOUND, A VANILLOID COMPOUND AND A CYTOPLASMIC GLYCOLYSIS REDUCTION AGENT
BRANDT,RALF, TOSH,DAVID, FELQUER,FERNANDO, CLAYTON,PAUL RODNEY, KENYON,JULIAN NORMAN
Year of Publication 17.07.2018
Get full text
Year of Publication 17.07.2018
Patent